Quality of life issues in the management of patients with ventricular arrhythmias

Canadian Journal of Cardiology

Volumn 16, Issue SUPPL. C, 2000, Pages

  Irvine, Jane ^a   Newman, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

DEFIBRILLATOR; DEPRESSION; HEART VENTRICLE TACHYCARDIA; HUMAN; METHODOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; DEFIBRILLATORS, IMPLANTABLE; DEPRESSIVE DISORDER; HUMANS; PSYCHOTHERAPY; QUALITY OF LIFE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0034199383     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. World Health Organization. The first ten years of the World Health Organization. Geneva: World Health Organization, 1958.
2. Bergner M, Bobbitt RA, Kressel S, et al. The Sickness Impact Profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 1976;6:393-415.
3. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985;35:185-8.
4. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Centre, 1993.
5. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions: health utilities index. PharmacoEconomics 1995;7:503-20.
6. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
7. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982;1:61-80.
8. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
9. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785-9.
10. Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction. Am J Cardiol 1991;67:121-7.
11. Allison TO, Williams DE, Miller TD, et al. Medical and economic costs of psychological distress in patients with coronary artery disease. Mayo Clin Proc 1995;70:734-42.
12. Herrmann C, von zur Muhen F, Schaumann A, et al. Standardized assessment of psychological well-being and quality-of-life in patients with implantable defibrillators. PACE 1997;20:95-103.
13. Thomas SA, Friedmann E, Wimbush F, Schron E. Psychosocial factors and survival in the Cardiac Arrhythmia Suppression Trial (CAST): A Reexamination. Am J Crit Care 1997;6:116-26.
14. Irvine J, Basinski A, Baker B, et al. Psychosocial predictors of sudden cardiac death in CAMIAT. Psychosom Med 1999;61:729-37.
15. Irvine J, Dorian P, Smith J, et al. Depression is associated with higher mortality in patients with a history of ventricular fibrillation/tachycardia. Psychosom Med 1999;61:126.
16. Pauli P, Wiedemann G, Dengler W, Blaumann-Bennnghoff G, Kuhlkamp V. Anxiety in patients with an automatic implantable defibrillator: What differentiates them from panic patients; Psychosom Med 1999;61:69-76.
17. Pycha C, Calabrese JR, Gulledge D, Maloney JD. Patient and spouse acceptance and adptation to implantable cardioverter defibrillators. Cleveland Clin J Med 1990;57:441-4.
18. Chevalier P, Verrier P, Kirkorian G, Touboul P, Cottraux J. Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator. A Psychometric Study. Psychother Psychosom 1996;65:49-56.
19. Ahem DK, Gorkin L, Anderson JL, et al, for the CAPS Investigators. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study. Am J Cardiol 1990;66:59-62.